… -metabolic high-dimensional data, we provide novel methods for precise disease monitoring
and stratification in order to effectively tailor clinical care to COVID-19 patients. Methods …

… In this respect inhibiting beside phosphorylation also the following steps of IκB inactivation,
ie ubiquitination and/or proteasome degradation may provide additional treatment options. …

… Thus, we believe that correct timing of these treatment options together with proper
thromboprophylaxis (36) is expected to improve the outcome of the COVID-19 patients. …

… characteristics and abnormal immunity of the confirmed COVID-19 non-survivors. Methods
… , the designated hospital for treating severe patients with COVID-19 in Wuhan, China. A total …

… antiviral therapeutic option to date available for COVID-19 … methods because of the
harsh death toll from this novel … Immune System need to be evaluated in light of COVID-19. …

… features in COVID-19 infection, followed by normal interactions between innate immune
system and viruses, background for cytokine storm secondary to COVID-19 infection, and finally …

… We propose that efficient treatments for COVID-19 patients should … COVID-19, none shows
high potency. We posit that the innate type 1 interferon (IFNα/β)-dependent antiviral immune …

… novel therapeutic options, we offer our perspective on the anti–COVID-19 immune
response… While both innate and adaptive immune activation likely contribute to COVID-19–mediated …

… coronavirus (SARS-CoV-2) is currently causing a severe outbreak of disease (termed COVID-19)
… findings, as well as treatment and prevention options for common circulating and novel …

… the alternatives of … COVID-19 immunity licenses can be assessed with respect to 3
fundamental ethical values: the maximization of benefit; priority to the least advantaged; and treating …